(Q44796385)

English

Second-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumors

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Second-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Amedeo Fiorillo

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Giuseppe Maggi

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Nicola Greco

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Roberta Migliorati

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Alessandra D'Amico

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Marialaura Della Basso De Caro

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

M Simona Sabbatino

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Floriana Buffardi

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

179-185

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

https://scigraph.springernature.com/pub.10.1023/b:neon.0000013471.53015.52

0 references

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy response rates in recurrent/progressive pediatric glioma; results of a systematic review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High concentration of Daunorubicin and Daunorubicinol in human malignant astrocytomas after systemic administration of liposomal Daunorubicin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of intravenous carboplatin for the treatment of recurrent gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma--a report of the Children's Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/B:NEON.0000013471.53015.52

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44796385&oldid=2042159447"